dc.contributor | Hospital General de Granollers |
dc.contributor.author | Teira, Ramon |
dc.contributor.author | Diaz-Cuervo, Helena |
dc.contributor.author | Aragão, F |
dc.contributor.author | Castaño, Manuel |
dc.contributor.author | Romero, Alberto |
dc.contributor.author | Roca, Bernardino |
dc.contributor.author | Deig, Elisabeth |
dc.contributor.author | Curran Fàbregas, Adria |
dc.date.accessioned | 2022-07-28T11:13:22Z |
dc.date.available | 2022-07-28T11:13:22Z |
dc.date.issued | 2022-04-11 |
dc.identifier.citation | Teira R, Diaz-Cuervo H, Aragão F, Castaño M, Romero A, Roca B, et al. Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort. Infect Dis Ther. 2022 Apr 11;11:1177-92. |
dc.identifier.uri | https://hdl.handle.net/11351/7940 |
dc.description | VIH; Triple teràpia; Combinacions de dos fàrmacs |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Infectious Diseases and Therapy;11 |
dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ |
dc.source | Scientia |
dc.subject | VIH (Virus) - Tractament |
dc.subject | Medicaments - Efectes fisiològics |
dc.subject | Medicaments - Eficàcia |
dc.subject.mesh | HIV Infections |
dc.subject.mesh | /drug therapy |
dc.title | Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s40121-022-00630-y |
dc.subject.decs | infecciones por VIH |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | https://doi.org/10.1007/s40121-022-00630-y |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Teira R] Service of Internal Medicine, Hospital de Sierrallana, Torrelavega, Spain. [Diaz-Cuervo H] Gilead Sciences, MAOR, London, UK. [Aragão F] Maple Health Group, New York City, NY, USA. NOVA National School of Public Health, Public Health Research Centre, Unversidade NOVA de Lisboa, Lisboa, Portugal. [Castaño M] Hospital Regional Universitario de Málaga, Málaga, Spain. [Romero A] Hospital Universitario de Puerto Real, Puerto Real, Spain. [Roca B] Hospital General de Castellón, Castellón, Spain. [Deig E] Hospital General de Granollers, Granollers, Spain. [Currán A] Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35399147 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |